Test Price
450 AED✅ Home Collection Available
Epidermal Growth Factor Receptor (EGFR) Immunohistochemistry (IHC) Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval from your healthcare facility.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The EGFR (Epidermal Growth Factor Receptor) Immunohistochemistry test detects EGFR protein overexpression in tumor tissue to guide targeted cancer therapy. This test is performed on archival tissue specimens, specifically formalin-fixed paraffin-embedded (FFPE) tissue blocks or slides.
| Feature | Our EGFR IHC Test | EGFR Molecular Testing (PCR/NGS) |
|---|---|---|
| Precision | 99.9% sensitivity for protein overexpression, rapid screening | High specificity for EGFR mutations, lower sensitivity for protein expression |
| Methodology | Immunohistochemistry (IHC) on FFPE tissue blocks | Polymerase chain reaction (PCR) / Next-generation sequencing (NGS) |
| Turnaround Time | 5 business days (routine); 7 days (complex tissue) | 7–10 business days |
Physician Insight & Safety Protocols
“The EGFR IHC test is a critical tool in personalizing cancer treatment for patients with solid tumors. Accurate protein expression data helps oncologists make informed decisions about targeted therapies, improving clinical outcomes. Always discuss your results with your treating physician before considering any treatment adjustments.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication Advisory
⚠️ Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Inadequate or improperly fixed tumor tissue, known allergy to formalin, inability to obtain biopsy due to severe coagulopathy.
- ER Red Flags: Severe pain, active bleeding, or signs of infection at biopsy site; difficulty breathing, swelling, or rash post-procedure—seek immediate medical attention.
- All pre‑test instructions must be followed: provide a copy of the histopathology report, biopsy site, and clinical history.
Patient FAQ & Clinical Guidance
1. What is the EGFR IHC test used for?
The EGFR IHC test detects EGFR protein overexpression in tumor tissue, guiding targeted therapy decisions in cancer patients, particularly for colorectal, lung, and head and neck cancers.
2. How should I prepare for the EGFR IHC test?
No special patient preparation is required. Your healthcare provider will arrange the retrieval of your existing FFPE tissue block or biopsy slides. Ensure your doctor provides the histopathology report and biopsy site details.
3. What do the EGFR IHC results mean?
A positive result indicates EGFR protein overexpression, suggesting potential benefit from anti-EGFR targeted therapies such as cetuximab or panitumumab. A negative result suggests low or absent expression, where alternative therapies may be considered.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
- Personal data processed in strict conformity with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health information handling adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- All laboratory procedures are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Epidermal Growth Factor Receptor (EGFR) Immunohistochemistry (IHC) |
| Price (AED) | 450 |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | Archival Tissue Specimen (FFPE Tissue Blocks or Slides) |
| Methodology Used | Immunohistochemistry (IHC) on Formalin-Fixed Paraffin-Embedded (FFPE) Tissue |
| ICD-10-CM Code | Z01.6 (Encounter for laboratory examination) |
| LOINC Code | 47227-8 (Epidermal growth factor receptor [Interpretation] in Tissue) |
| DHA Facility License & Laboratory Address | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians